Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fibrogen Inc CS (FGEN)

Fibrogen Inc CS (FGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
FibroGen: Q4 Earnings Snapshot

FibroGen: Q4 Earnings Snapshot

FGEN : 1.0200 (+3.63%)
FibroGen: Q3 Earnings Snapshot

FibroGen: Q3 Earnings Snapshot

FGEN : 1.0200 (+3.63%)
Stocks Move Higher Before the Open as Investors Await Key U.S. GDP Data, Salesforce Earnings on Tap

September S&P 500 futures (ESU23) are up +0.06%, and September Nasdaq 100 E-Mini futures (NQU23) are up +0.07% this morning after three major U.S. benchmark indices rallied on Tuesday as soft economic...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
CTLT : 55.80 (-0.27%)
PDD : 125.79 (-1.38%)
VZ : 39.22 (-0.68%)
T : 16.58 (-1.37%)
CRM : 273.14 (-1.10%)
CRWD : 298.02 (+0.13%)
CHWY : 15.38 (+1.92%)
ORSTE.C.DX : 379.200 (-0.65%)
PRU.LN : 714.000 (-2.88%)
HPQ : 28.13 (+0.11%)
FibroGen: Q2 Earnings Snapshot

FibroGen: Q2 Earnings Snapshot

FGEN : 1.0200 (+3.63%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FibroGen, Inc. - FGEN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN). Such investors are...

FGEN : 1.0200 (+3.63%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FibroGen, Inc. - FGEN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN). Such investors are...

FGEN : 1.0200 (+3.63%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FibroGen, Inc. - FGEN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN). Such investors are...

FGEN : 1.0200 (+3.63%)
Down 80% in 1 Day, Is There Any Hope for FibroGen Stock?

Its pipeline is looking thin, and it might hit another speed bump quite soon.

FGEN : 1.0200 (+3.63%)
FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates

FibroGen (FGEN) delivered earnings and revenue surprises of -6.58% and 17.02%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

FGEN : 1.0200 (+3.63%)
CTIC : 9.09 (unch)
FibroGen: Q1 Earnings Snapshot

FibroGen: Q1 Earnings Snapshot

FGEN : 1.0200 (+3.63%)

Barchart Exclusives

Guess vs. Levi Strauss: Which Breakout Dividend Stock Is a Better Buy?
With Levi Strauss and Guess stock prices surging and both apparel giants impressing shareholders with their dividend payments, which of the two is a better buy? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar